SUNPHARMAPharmaceuticals · NSE

Sun Pharmaceutical Industries in the news

Made the news 4 times since we started tracking. Newest first.

• 2 Nov 2026 · Stocks to watchResultsSun Pharma's Q2 profit falls 36% to ₹1,989 crore after a ₹1,269 crore one-time lossSun Pharma's September-quarter consolidated profit was ₹1,989 crore against ₹3,118 crore a year earlier, Upstox and Business Today reported, on revenue up 12% to ₹16,199 crore.
• 21 Oct 2026RegulatorySun Pharma's Unloxcyt gets NCCN 2A preferred status for locally advanced skin cancerSun Pharma said Unloxcyt (cosibelimab-ipdl) now holds a Category 2A preferred designation in the US NCCN guidelines for locally advanced cutaneous squamous cell carcinoma.
• 14 Oct 2026 · Stocks to watchCorporate actionsSun Pharma's board approves up to ₹10,000 crore of debentures; a director resignsSun Pharma's board approved a private placement of non-convertible debentures of up to ₹10,000 crore. Independent director Gautam Doshi resigned with immediate effect.
• 29 Sep 2026Deals & fundingSun Pharma licenses cholesterol drug lerodalcibep for markets outside the US and ChinaSun Pharma signed an exclusive licensing deal with LIB Therapeutics to sell and make the once-monthly cholesterol injection lerodalcibep outside the US and China.